BR0012921A - Compostos calcilìticos - Google Patents

Compostos calcilìticos

Info

Publication number
BR0012921A
BR0012921A BR0012921-6A BR0012921A BR0012921A BR 0012921 A BR0012921 A BR 0012921A BR 0012921 A BR0012921 A BR 0012921A BR 0012921 A BR0012921 A BR 0012921A
Authority
BR
Brazil
Prior art keywords
compounds
calcally
disorders
calculating
new methods
Prior art date
Application number
BR0012921-6A
Other languages
English (en)
Inventor
Maxine Gowen
Larry J Suva
John Fox
George B Stroup
Esward F Nemeth
Original Assignee
Smithkline Beecham Corp
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Nps Pharma Inc filed Critical Smithkline Beecham Corp
Publication of BR0012921A publication Critical patent/BR0012921A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSTOS CALCILìTICOS". São providenciados novos métodos de tratamento de doenças ou distúrbios do osso.
BR0012921-6A 1999-07-31 2000-07-31 Compostos calcilìticos BR0012921A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14677899P 1999-07-31 1999-07-31
PCT/US2000/020834 WO2001008673A1 (en) 1999-07-31 2000-07-31 Calcilytic compounds

Publications (1)

Publication Number Publication Date
BR0012921A true BR0012921A (pt) 2002-06-18

Family

ID=22518969

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012921-6A BR0012921A (pt) 1999-07-31 2000-07-31 Compostos calcilìticos

Country Status (21)

Country Link
EP (1) EP1200076A4 (pt)
JP (1) JP2003505502A (pt)
KR (1) KR20020016928A (pt)
CN (1) CN1367687A (pt)
AU (1) AU764716B2 (pt)
BR (1) BR0012921A (pt)
CA (1) CA2380081A1 (pt)
CO (1) CO5180628A1 (pt)
CZ (1) CZ2002360A3 (pt)
EC (1) ECSP003590A (pt)
HK (1) HK1046238A1 (pt)
HU (1) HUP0202167A3 (pt)
IL (1) IL147875A0 (pt)
MX (1) MXPA02001204A (pt)
NO (1) NO20020466L (pt)
PE (1) PE20010459A1 (pt)
PL (1) PL353318A1 (pt)
TR (1) TR200200278T2 (pt)
UY (1) UY26265A1 (pt)
WO (1) WO2001008673A1 (pt)
ZA (1) ZA200200784B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030684A1 (es) * 2000-01-24 2003-09-03 Smithkline Beecham Corp Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
MY143244A (en) 2002-11-26 2011-04-15 Smithkline Beecham Corp Calcilytic compounds
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
TW200845956A (en) * 2006-12-18 2008-12-01 Smithkline Beecham Corp Calcilytic compounds
EP2797591A1 (en) * 2011-12-27 2014-11-05 Ubaldo Armato Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
CN108420814A (zh) * 2017-02-15 2018-08-21 四川大学 一种nps-2143用于抗菌的新用途
CN116173187B (zh) * 2023-03-14 2024-05-10 哈尔滨医科大学 降钙素在制备防治支架内再狭窄药物中的应用、药物涂层支架及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG99290A1 (en) * 1996-04-09 2003-10-27 Nps Pharma Inc Calcilytic compounds
AR014975A1 (es) * 1998-04-08 2001-04-11 Nps Pharma Inc Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento
PE20000415A1 (es) * 1998-04-08 2000-05-21 Smithkline Beecham Corp Compuestos calciliticos

Also Published As

Publication number Publication date
ECSP003590A (es) 2002-02-25
KR20020016928A (ko) 2002-03-06
PL353318A1 (en) 2003-11-17
NO20020466L (no) 2002-03-20
CA2380081A1 (en) 2001-02-08
HUP0202167A3 (en) 2006-07-28
CN1367687A (zh) 2002-09-04
HUP0202167A2 (en) 2002-10-28
IL147875A0 (en) 2002-08-14
ZA200200784B (en) 2003-01-29
CO5180628A1 (es) 2002-07-30
AU764716B2 (en) 2003-08-28
EP1200076A1 (en) 2002-05-02
UY26265A1 (es) 2001-03-16
HK1046238A1 (zh) 2003-01-03
EP1200076A4 (en) 2005-02-09
WO2001008673A1 (en) 2001-02-08
NO20020466D0 (no) 2002-01-29
MXPA02001204A (es) 2004-05-21
CZ2002360A3 (cs) 2002-10-16
PE20010459A1 (es) 2001-06-11
JP2003505502A (ja) 2003-02-12
TR200200278T2 (tr) 2002-06-21
AU6504100A (en) 2001-02-19

Similar Documents

Publication Publication Date Title
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
GB0108592D0 (en) Therapeutic agents
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
WO2002002520A3 (en) Compounds to treat alzheimer's disease
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
MXPA02001204A (es) Compuestos calciliticos.
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
ATE330604T1 (de) Behandlung von manischen erkrankungen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
NO20005548L (no) Mykobakterieinhibitorer
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
TR200003084T2 (tr) Paroxetine askorbat
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
NO20006383L (no) Fremgangsmåte for behandling
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
ATE236159T1 (de) Neuartige bispidin-derivate, die sich zur behandlung von herzrhythmusstörungen eignen

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.